市场调查报告书
商品编码
1452632
北美医疗快递市场预测至 2030 年 - 区域分析 - 按产品类型、目的地、服务和最终用户North America Medical Courier Market Forecast to 2030 - Regional Analysis - By Product Type, Destination, Service, and End Users |
2022年北美医疗快递市场价值为22.7026亿美元,预计到2030年将达到34.4137亿美元;预计 2022 年至 2030 年CAGR为 5.3%。
慢性病盛行率上升推动北美医疗快递市场
根据 IDF 糖尿病地图集第 10 版,到 2021 年,十分之一的成年人,即 5.37 亿人患有糖尿病(20-79 岁)。到2030年和2045年,这一数字预计将分别增加至6.43亿和7.83亿。此外,2021 年,糖尿病导致 670 万人死亡,即每五秒钟就有一人死亡。此外,肾臟疾病是全球主要的公共卫生问题。慢性肾臟病 (CKD) 和急性肾损伤 (AKI) 都会对健康造成严重的负面后果、巨额医疗费用和低生活品质。每年,数百万成年人因慢性肾臟病 (CKD) 相关併发症而早逝,占所有成年人死亡人数的 8-10%。此外,根据全球疾病负担合作网络《2019 年全球疾病负担研究》,全球每年有 4,100 万人因非传染性疾病 (NCD) 死亡,占总死亡人数的 74%。每年有 1700 万人在 70 岁前死于非传染性疾病;低收入和中等收入国家占这些过早死亡的 86%。 77% 的非传染性疾病相关死亡发生在低收入和中等收入国家。大多数非传染性疾病死亡(每年1,790 万人)是由心血管疾病引起的,其次是癌症(930 万人)、慢性呼吸道疾病(410 万人)和糖尿病(200 万人,包括糖尿病引起的肾臟疾病死亡) )。这四类疾病导致 80% 以上的早期非传染性疾病死亡。吸烟、空气污染、不良饮食、有害饮酒和缺乏运动会增加死于非传染性疾病的风险。
因此,全球糖尿病、慢性肾臟病、非传染性疾病等慢性病病例的增加同时推动了对医疗用品的需求,并对医疗快递市场的成长产生积极影响。
北美医疗快递市场概况
北美医疗快递市场分为美国、加拿大和墨西哥。 2022年,美国在该地区占据最大市场份额,预计在预测期内将继续保持主导地位。北美医疗快递市场的预期成长归因于肾臟、肝臟和心臟等器官衰竭病例数量的增加,导致器官移植手术数量的增加。器官衰竭病例的增加可能与心臟、肾臟和肝臟相关慢性疾病盛行率的激增有关,这刺激了器官移植的需求。根据器官采购和移植网络的数据,2022 年美国进行了超过 42,800 例器官移植,年增长率约为 3.7%。根据加拿大健康资讯研究所 (CIHI) 的数据,2021 年加拿大进行了约 2,750 例器官移植。美国国立卫生研究院 (NIH) 公布的数据表明,约 8,500 例移植手术,包括角膜、肾臟、肝臟和2019年3 月至2021 年2 月在墨西哥进行了心臟移植手术。在器官移植过程中,可能需要将器官从一家医院转移到另一家医院。医疗快递企业提供在适当储存条件下按时运输这些器官的服务。医疗快递服务提供者采用重要的病患照护程序,并确保记录、报告、医疗用品和实验室用品的及时有效的运输。根据美国劳工统计局的数据,2022年美国医疗行业将有约18,000名员工,约占快递行业总就业人数的4.5%。由于样品需求不断增长,医疗快递行业的就业人数不断增加整体治疗药物正在推动市场的成长。此外,在预测期内,医疗保健设施的持续技术进步可能有利于北美医疗快递市场。 2020 年,UPS Flight Forward 和 CVS 合作,从 CVS 药房向佛罗里达州 The Villages 运送处方药,该社区是美国最大的退休人员社区,拥有超过 135,000 名居民。
北美医疗快递市场收入及 2030 年预测(百万美元)
北美医疗快递市场细分
北美医疗快递市场根据产品类型、目的地、服务、最终用户和国家进行细分。
根据产品类型,北美医疗快递市场分为医疗用品和设备、血液和器官、实验室标本、医疗笔记等。 2022年,医疗用品和设备领域占最大份额。
按目的地划分,北美医疗快递市场分为国内和国际。 2022 年,国内市场占更大份额。
依服务划分,北美医疗快递市场分为标准服务及加急及按需服务。 2022 年,标准服务和加急服务将占据更大份额。
就最终用户而言,北美医疗快递市场分为医院和诊所、诊断实验室、血液和组织库、药房、家庭支援、製药和生物技术公司等。 2022 年,医院和诊所部门占最大份额。
根据国家/地区,北美医疗快递市场分为美国、加拿大和墨西哥。 2022年,美国在北美医疗快递市场占据主导地位。
德国邮政股份公司、联邦快递、MNX 全球物流公司、联合包裹服务公司和 Zipline 国际公司是北美医疗快递市场上的一些领先公司。
The North America medical courier market was valued at US$ 2,270.26 million in 2022 and is expected to reach US$ 3,441.37 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.
Rising Prevalence of Chronic Diseases Fuels the North America Medical Courier Market
A per the IDF Diabetes Atlas 10th edition, in 2021, One in ten adults, or 537 million, have diabetes (20-79 years old). By 2030 and 2045, this number is expected to increase to 643 million and 783 million, respectively. Further, in 2021, diabetes caused 6.7 million fatalities, or one every five seconds. Furthermore, kidney disease is a major global public health concern. Both chronic kidney disease (CKD) and acute kidney injury (AKI) are associated with significant negative health consequences, substantial medical expenses, and a low quality of life. Every year, millions of adults die early from complications associated with chronic kidney diseases (CKD), accounting for 8-10% of all adult deaths. Also, according to Global Burden of Disease Collaborative Network, Global Burden of Disease Study 2019, noncommunicable diseases (NCDs) account for 41 million annual deaths worldwide, or 74% of all fatalities. 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. 77% of NCD-related deaths occur in low- and middle-income nations. The majority of NCD deaths-17.9 million annually-are caused by cardiovascular illnesses, which are followed in death by cancer (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million, including deaths from renal disease induced by diabetes). These four categories of diseases cause more than 80% of all early NCD fatalities. Smoking, air pollution, poor diets, hazardous alcohol use, and physical inactivity increase the chance of dying from an NCD.
Thus, the increasing cases of chronic diseases such as diabetes, CKD, NCDs worldwide is simultaneously propelling the demand for medical supplies and positively influencing the medical courier market growth.
North America Medical Courier Market Overview
The North America medical courier market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The projected growth of the North America medical courier market in North America is attributed to the increasing number of organ transplant surgeries owing to a rise in the number of organ failure cases such as kidney, liver, and heart. The rise in organ failure cases can be associated with a surge in the prevalence of chronic diseases related to the heart, kidney, and liver, which fuels the demand for organ transplants. According to the Organ Procurement & Transplantation Network, more than 42,800 organ transplants were performed in the US in 2022, reporting an annual increase of ~3.7%. According to the Canadian Institute of Health Information (CIHI), ~2,750 organ transplantations were carried out in Canada in 2021. Data published by the National Institutes of Health (NIH) states that ~8,500 transplantation procedures, including cornea, kidney, liver, and heart, were performed in Mexico from March 2019 to February 2021. During organ transplants, there may be a necessity to transfer the organ from one hospital to another. Medical courier businesses provide services to transport these organs on time in proper storage conditions. Medical courier service providers adopt vital patient care procedures, and ensure the prompt and efficient transportation of records, reports, medical supplies, and laboratory supplies. According to the US Bureau of Labor Statistics, ~18,000 employees-approximately 4.5% of the total courier industry employment-were employed in the medical industry in the US in 2022. The increasing employment in the medical courier industry due to the growing demand for samples and medicines for overall treatment is fueling the growth of the market. Further, the ongoing technological advancements in healthcare facilities are likely to benefit the North America medical courier market in North America during the forecast period. In 2020, UPS Flight Forward and CVS partnered to deliver prescription medicines from CVS pharmacy stores to The Villages, Florida, the largest retired people's community in the US, which is home to more than 135,000 residents.
North America Medical Courier Market Revenue and Forecast to 2030 (US$ Million)
North America Medical Courier Market Segmentation
The North America medical courier market is segmented based on product type, destination, service, end users, and country.
Based on product type, the North America medical courier market is segmented into medical supplies and equipment, blood and organs, lab specimens, medical notes, and others. The medical supplies and equipment segment held the largest share in 2022.
By destination, the North America medical courier market is bifurcated into domestic and international. The domestic segment held a larger share in 2022.
By service, the North America medical courier market is bifurcated into standard service and rush and on-demand services. The standard service and rush segment held a larger share in 2022.
In terms of end users, the North America medical courier market is categorized into hospital and clinics, diagnostic labs, blood and tissue banks, pharmacy, in home support, pharmaceutical and biotechnology companies, and others. The hospital and clinics segment held the largest share in 2022.
Based on country, the North America medical courier market is segmented into the US, Canada, and Mexico. The US dominated the North America medical courier market in 2022.
Deutsche Post AG, FedEx Corp, MNX Global Logistics Corp, United Parcel Service Inc, and Zipline International Inc are some of the leading companies operating in the North America medical courier market.